Concepedia

Julian Hickling

JH

Statistics

Publications

26

Citations

2.7K

H-Index

20

Active since

1987

Affiliations

World Health Organization(Current)

The University of Queensland

Cancer Research UK Manchester Institute

Vaxxas (Australia)

The University of Melbourne

Julian Hickling is an author at World Health Organization specializing in immunology, vaccination, and vaccinology.

Publications per year

1987–2023

26

Publications

26

A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer

Leszek K. Borysiewicz, Alison Fiander, M. Nimako et al. · The Lancet · 1996 · 530 citations

Life Sciences, Infectious Diseases, Oncology +15

Human cytomegalovirus-specific cytotoxic T cells. Relative frequency of stage-specific CTL recognizing the 72-kD immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses.

Leszek K. Borysiewicz, Julian Hickling, Shek Graham et al. · The Journal of Experimental Medicine · 1988 · 249 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.

Andreas M. Kaufmann, Peter L. Stern, Elaine M. Rankin et al. · PubMed · 2002 · 204 citations

Medicine, Immunology, Oncology +17

Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia.

Peter Baldwin, Sjoerd H. van der Burg, Christopher M. Boswell et al. · PubMed · 2003 · 174 citations

Medicine, Immunology, Oncology +17

Immunological and clinical responses in women with vulval intraepithelial neoplasia vaccinated with a vaccinia virus encoding human papillomavirus 16/18 oncoproteins.

Emma J. Davidson, Christopher M. Boswell, Peter Sehr et al. · PubMed · 2003 · 171 citations

Medicine, Immunology, Oncology +17

1–5 of 26